Autobio
Autobio
Autobio forming a pattern of immunodiagnostic products and microbiological te
Founded in 1999, Antu Biological is specialized in the development, production and sales of in vitro diagnostic reagents and instruments, forming a pattern of immunodiagnostic products and microbiological testing products. The company's products cover a wide range of testing fields from infectious diseases to non-infectious diseases, and can meet the various testing needs of end users. The reagents cover infectious diseases, tumors, reproductive endocrinology, thyroid function, liver fibrosis, eugenics, diabetes, hypertension, heart disease, genitourinary tract diseases, respiratory diseases, bacterial isolation and culture, identification and susceptibility analysis and other testing fields. In addition, the company has always insisted on the joint development of reagents and instruments, and the related equipment covers chemiluminescence immunoassay analyzer, enzyme labeling instrument, plate washer, laboratory analyzer, automatic sample processing system, automatic chemiluminescence analyzer and other products.
- All
- News
- Analysis
- Research
Briefing Feb 21, 2023 11:10 AM
· Healthcare
We-Linking Raised Over CNY 10 Mn in Angel Round
Briefing Feb 21, 2023 10:07 AM
· Healthcare
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
In-depth
Healthcare
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Briefing Feb 15, 2023 12:32 PM
· Healthcare
ZD Medtech Raised Over CNY 100 Mn in Series B
Briefing Feb 13, 2023 12:54 PM
· Healthcare
Smart Powered Bionic Prosthetic Star BionicM Nets Over CNY 10 Mn
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 22, 2021 03:11 PM
Briefing Feb 08, 2023 11:44 AM
· Healthcare
Medical Technology Company MacroLux Nets Nearly CNY 100 Mn in Series A
Briefing Jan 31, 2023 11:02 AM
· Healthcare
Fine Vision Completes Angel Financing Round Worth Nearly CNY 50 Mn
Briefing Jan 28, 2023 11:20 AM
· Healthcare
YingHe Neuro Raises Over CNY 100 Mn in Angel Round
Briefing Jan 17, 2023 10:36 AM
· Healthcare
Medical Equipment Company PowerSite Nets Over CNY 100 Mn in Series B
Healthcare
SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year
EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.
Jun 06, 2024 06:18 PM
Briefing Oct 12, 2021 05:44 PM
· Healthcare
Nippon instruments: the profit in the first three quarters is expected to drop by 58% - 63%
Briefing Aug 20, 2021 09:48 AM
· Healthcare
Pharmaceutical and medical stocks fell sharply in early trading, and Hengrui pharmaceutical fell more than 9%
Briefing Jul 21, 2021 11:08 AM
· Healthcare
Antu biological: no impact on production and operation, emergency measures have been launched
See more
Related Companies
EqualOcean Analysis
- Robo CT Partner Wang Xiaoqi: Winning the International Stage with Manufacturing Excellence
- Pure Global: The International Engine of Medical Technology Globalization
- MGI Tech: Lead Life Science Through Intelligent Innovation
- China's "Top Student" Takes on the "International Exam": United Imaging's Path to Overseas
- 20 Chinese Companies to Watch in Q1 2023– Healthcare+